CONTEXT: Commercial announcement of a tie up between TriNetX and Takeda to develop the latter’s use of RWD in their overall trail design strategy.
IMPACT: Low
READ TIME: 1 min
Quality Level Mean [1 – 10]: 6
1. ““This is a key step in our strategy of embedding real-world data into all aspects of drug development and commercialization to deliver on our commitment to bring medicines to patients faster.””
2. “TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced today it has entered into an agreement with Takeda Pharmaceutical Company Limited (“Takeda”) to unlock the value of real-world data (RWD) and accelerate the delivery of transformative therapies to patients.”
3. ““Since the outset of the global COVID-19 pandemic, our teams have leveraged TriNetX’s real-time data to understand the natural history of the disease and to inform clinical trial design and execution,” said Kathleen Gondek, Head of Global Evidence and Outcomes at Takeda.”
4. “Also Read: Ways CIOs Can Digitally Transform Businesses in 2021. TriNetX is the largest and fastest-growing collaborative research network and RWD platform representing over 170 healthcare organizations (HCOs) and health data partners, spanning countries across the globe.”
5. ““We are pleased to be a part of Takeda’s real-world data and evidence strategy,” said Mike Sullivan, Senior Director, Commercial Sales at TriNetX.”